Walid Kamoun, Vice President, Global Head of R&D Oncology at Servier, shared a post on LinkedIn:
“Thrilled to be in China this week visiting world-class clinical and research centers in Shanghai and Beijing.
Our focus is clear: connecting with top-notch brain tumor centers and the local ecosystem to forge partnerships that accelerate innovation. At Servier, we are deeply committed to developing transformative therapies for brain tumor patients.
Great to be traveling with Julien Boone (Global Head of Oncology Asset Strategy) and Francois Lehembre (Global Head of Oncology Research), with the fantastic support of our local team.
Stay tuned – a photo with the full team is coming tomorrow before we kick off!”
Julien Boone, Global Head of Oncology Asset Strategy at Servier, shared a post by Walid Kamoun, adding:
“In China this week, together with Walid Kamoun and Francois Lehembre leading clinical and research centers across Shanghai and Beijing.
The objective is clear: connect with top brain tumor centers and engage with the local ecosystem to build partnerships that accelerate innovation.
At Servier, our commitment is strong – advancing transformative therapies for patients living with brain tumors and working together with global partners to bring new hope to those who need it most.”
Other articles featuring Walid Kamoun on OncoDaily.